NMDA receptor (NMDAR) antagonists are dissociative anesthetics, drugs of abuse, and are of therapeutic interest in neurodegeneration and neuropsychiatric disease. Many well-known NMDAR antagonists are positively charged, voltage-dependent channel blockers. We recently showed that the hydrophobic anion dipicrylamine (DPA) negatively regulates GABA A receptor function by a mechanism indistinguishable from that of sulfated neurosteroids. Because sulfated neurosteroids also modulate NMDARs, here we examined DPA's effects on NMDAR function. In rat hippocampal neurons DPA inhibited currents gated by 300 µM NMDA with an IC 50 of 2.3 µM. Neither onset nor offset of antagonism exhibited dependence on channel activation but exhibited a non-competitive profile. DPA antagonism was independent of NMDAR subunit composition and was similar at extrasynaptic and total receptor populations. 
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Introduction NMDA receptors (NMDARs) have been the object of intense investigation for more than three decades. NMDAR channels exhibit gating contingent on both agonist binding and on membrane potential. As such, NMDARs are molecular coincidence detectors of presynaptic glutamate release and postsynaptic activity (Dingledine et al., 1999; Nakazawa et al., 2004) .
The voltage dependence of gating, along with Ca 2+ permeability of the channels, imbues
NMDARs with properties important for roles in synaptic development and neuroplasticity (Collingridge et al., 2004; Lu et al., 2001 HEPES, 0.5 CaCl 2 , and 5 EGTA at pH 7.25, unless otherwise indicated. When filled with this solution, pipette tip resistance was 3-6 MΩ. Cells were usually clamped at -70 mV or as indicated in figure legends. Membrane capacitance was estimated by examining the integrated capacitive current (sampled at 50 kHz at 10 kHz filter cutoff frequency) to 5-20 mV depolarizing or hyperpolarizing voltage pulses. Drugs were applied with a multibarrel, gravity-driven local perfusion system that provides a laminar local stream for solution exchanges. Most NMDAcontaining solutions were applied in low Ca 2+ saline (0.25 -0.5 mM) to diminish Ca 2+ dependent desensitization (Clark et al., 1990; Tong et al., 1995) and were nominally devoid of Mg 2+ and D-APV. The common tip was placed 0.5 mm from the center of the microscope field. Solution exchange times were 120 ± 14 ms (10-90% rise), estimated from junction current rises at the tip of an open patch pipette. Experiments were performed at room temperature.
For isolation of extrasynaptic NMDARs, solitary neurons were grown on astrocyte islands (Mennerick et al., 1995) . Autaptic, recurrent EPSCs were elicited with a brief depolarizing MOL #81794
Oocyte responses to NMDA were recorded 2-5 days following RNA injection using a twoelectrode voltage clamp (OC725C amplifier, Warner Instruments) at a membrane potential of −70 mV. The bath solution was ND96 solution with the following changes: Mg 2+ was omitted, Ba 2+ replaced Ca 2+ to avoid activation of endogenous Ca 2+ -dependent currents, and 10 µM glycine was added. Glass recording pipettes ( 1 MΩ resistance) were filled with 3 M KCl.
Compounds were applied to the oocytes using a multibarrel pipette with a common output tip.
Data acquisition and analysis were performed with pCLAMP software (Molecular Devices, Sunnyvale, CA). At the higher concentrations employed in this study (≥ 1 µM), DPA sometimes elicited a small D-APV insensitive inward steady current of unclear origin. To avoid confusing this effect with potentiation of NMDA responses, we pre-applied DPA prior to co-application with NMDA (e.g. Figure 1 ), and for quantification we subtracted the DPA-induced current. The small current was inconsequential at high NMDA concentrations, which generated currents much larger than the DPA-induced current.
Data analysis. Data acquisition and analysis were performed primarily using pCLAMP 10 software (Molecular Devices). Inhibition by antagonists was measured by quantifying the peak response to NMDA or, in the case of sustained antagonist application, by quantifying the average current during the final 50-100 ms of drug application. Extended analysis was done using Microsoft Excel (Microsoft, Redmond, WA) or GraphPad Prism (GraphPad Software, La Jolla, CA). Graphical figures and curve fitting were conducted with Clampfit (Molecular Devices) or SigmaPlot software (SPSS Science, Chicago, IL). Data are expressed as mean ± SEM.
Statistical significance was determined using a Student's two-tailed t-test or two-way, repeatedmeasures ANOVA, as indicated. Curve fitting of dose-response data was performed with the Hill equation [I = I max C n / (EC 50 n + C n )], where C is the agonist concentration, I max is the maximum current amplitude, EC 50 is the agonist concentration that yields a 50% response relative to I max , and n is the Hill coefficient. Curve fits to the Boltzmann function were to an This article has not been copyedited and formatted. The final version may differ from this version. Max is the upper asymptote, V 1/2 is the half-maximum voltage, and S is the slope factor (RT/zF).
Materials. All compounds were obtained from Sigma-Aldrich (St. Louis, MO) except for DPA, which was obtained from Biotium (Hayward, CA). DPA was supplied as DMSO stock or as powder from the supplier. We noticed no obvious differences in the behavior of several different DPA samples.
Results

DPA is non-competitive and use independent
We focused on DPA because we recently characterized it as a very potent, uncompetitive antagonist of GABA A Rs and because it is a compound of interest as a probe of neuronal excitability (Bradley et al., 2009; Chanda et al., 2005a; Chanda et al., 2005b; Chisari et al., 2011) . At GABA A Rs, DPA exhibits similar antagonism to that of sulfated neurosteroids, which also modulate NMDARs (Gibbs et al., 2006; Park-Chung et al., 1997) . To evaluate DPA effects on NMDARs, we first examined recombinant GluN1a/GluN2A NMDARs expressed in oocytes, where complete NMDA concentration-response curves could be readily obtained in the presence and absence of pre-applied DPA ( Figure 1A , B). This analysis showed that DPA exhibited a non-competitive profile of antagonism, lowering the apparent efficacy (maximum responses) to NMDA but significantly reducing the NMDA EC 50 ( Figure 1B) . Subsequent experiments were performed in neurons and HEK cells to take advantage of more rapid drug delivery.
Hippocampal neurons exhibited somewhat higher sensitivity to DPA antagonism of NMDA currents. At a NMDA concentration of 300 µM, DPA exhibited an IC 50 of 2.3 µM in dissociated cultures of postnatal rat hippocampal neurons ( Figure 1C , D) and a higher IC 50 of 15.7 ± 4.0 µM in Xenopus oocytes expressing GluN1/GluN2A NMDAR subunits (N = 6; data not shown).
Whether this difference in sensitivity is related to NMDAR subunit composition or to cell type was addressed in ensuing experiments. In both cases, the IC 50 was higher than that for antagonism of GABA A Rs (Chisari et al., 2011) , paralleling the difference in potency of neurosteroids at the two receptor types.
Despite superficial similarities to neurosteroids (non-competitive antagonism, sensitivity of NMDARs and GABA A Rs), DPA's actions on NMDARs were distinct from at least some neurosteroid antagonists. For example, the neurosteroid 3α5βS is characterized by usedependent antagonism and requires channel opening for inhibition (Borovska et al., 2012; Petrovic et al., 2005) . When applied to pre-activated receptors, DPA (2 µM) inhibited steadystate responses to 300 µM NMDA by 62.9 ± 1.9% (N = 3; Figure 2A , left). Antagonism exhibited characteristic slow onset and offset. To test whether inhibition required channel opening, we pre-applied DPA to closed NMDARs, followed by application of NMDA alone ( Figure 2A , right) (Borovska et al., 2012) . Pre-application of DPA for 10 s inhibited peak responses to NMDA by 48.9 ± 2.0%, while steady-state current after pre-application of DPA was comparable to the steady-state current after co-application of DPA and NMDA (111.2 ± 24.3%).
Thus, although the shift in EC50 in Figure 1B data could suggest a use-dependent (uncompetitive) mechanism of antagonism, these latter data suggest that DPA antagonism is not use dependent. We further examined the effect of 1 µM DPA on peak and steady-state NMDA currents when pre-applied DPA was followed by co-application with NMDA. DPA had similar effects on peak and steady-state NMDA current ( Figure 2B ; 33.9 ± 3.4% inhibition of peak, and 29.0 ± 12.9% inhibition of steady-state current; N = 5), again suggesting little or no dependence of antagonism on channel activation.
This article has not been copyedited and formatted. The final version may differ from this version. In contrast to results in Figure 2A , the well-characterized use-dependent channel blocker ketamine (2.5 µM) exhibited a requirement for channel activation ( Figure 2C ). Application of ketamine (10 s) during NMDA application inhibited steady-state NMDA responses by 84.2 ± 2.9% (N = 3; Figure 2C ). When solely pre-applied for the same amount of time, ketamine inhibited peak NMDA current by (26.9 ± 5.1%, Figure 2C , dotted line), and steady-state responses were 635.9 ± 151.6% larger than currents following ketamine wash out during NMDA application ( Figure 2C , dashed line). The modest peak reduction is consistent with lipophilic retention of ketamine following aqueous removal (Orser et al., 1997) , while the steady-state effects demonstrate clear activation dependence of ketamine onset and offset.
Cationic pore blockers like ketamine are characterized by "trapping" within the NMDAR ion channel, where offset of inhibition by the antagonist is accelerated in the presence of agonist (Mealing et al., 1999) . To address whether DPA antagonism is affected similarly, DPA (3 µM) was applied to neurons after achieving steady-state NMDA current (300 µM), and then washed from the cell for 30 s in the presence of NMDA ( Figure 2D , top), or in the presence of saline ( Figure 2D , bottom) with brief pulses of NMDA to determine the degree of inhibition at two time points. At both points, the level of inhibition of NMDA current by DPA was similar ( Figure 2E ), suggesting that the offset of inhibition by DPA is not affected by the presence of NMDA.
DPA is a broad spectrum NMDAR antagonist
Some non-competitive NMDAR antagonists exhibit subunit selectivity, making them valuable tools for the study of specific receptor populations in plasticity and other NMDAR functions.
GluN2A and GluN2B are the major non-obligate NMDAR subunits in the hippocampus, while
GluN2C and GluN2D are present in some hippocampal interneurons (Monyer et al., 1994) . We examined subunit selectivity of DPA in hippocampal neurons using the GluN2B-selective blocker ifenprodil to isolate GluN2A-containing receptors ( Figure 3A ). Ifenprodil (10 µM) blocks
This article has not been copyedited and formatted. The final version may differ from this version. approximately half of the whole-cell NMDA current under these conditions (Chang et al., 2010) .
DPA (1 µM) modulation of isolated GluN2A-containing receptors was similar to effects on the total population of receptors (0.63 ± 0.03; N = 5; compare with Figure 1C ). This result suggests that there is unlikely to be any selective effect of DPA on particular subunit combinations in native cells, although our results do not exclude selective effects on heterotrimeric receptors.
The effect of DPA on the GluN2A population in hippocampal neurons appeared to be more potent than on these subunits expressed in oocytes ( Figure 1A , B). HEK293 cells behaved more like neurons (Figure 3) , and there was no detectable difference in antagonism by a fixed DPA concentration among GluN1a/GluN2A, GluN1a/GluN2B, GluN1a/GluN2C, and ( Figure 4A3 ; N = 4), consistent with previous estimates of the strong contribution of synaptic receptors to the total NMDAR pool (Harris and Pettit, 2007; Rosenmund et al., 1995; Wroge et al., 2012) . We found that these NMDA responses, attributable mainly to extrasynaptic NMDARs, were inhibited by DPA (1 µM) similarly to the total NMDAR pool ( Figure 4B ).
Comparable results were obtained by incubating mass cultures in MK-801 to allow spontaneous synaptic activity to drive NMDAR block (data not shown). We used an MK-801 incubation
This article has not been copyedited and formatted. The final version may differ from this version. protocol previously shown to block nearly all synaptic receptors in this preparation (Hardingham et al., 2002; Huettner and Bean, 1988; Wroge et al., 2012) . Following MK-801 inhibition, extrasynaptic responses were inhibited 35.2 ± 4.4% by 1 µM DPA (N = 9, compare with Figure   4B ). Taken together, these two experiments suggest that DPA exhibits no selectivity for either synaptic or extrasynaptic NMDAR populations.
DPA voltage dependence
DPA exhibits well-characterized, voltage-dependent translocation across the plasma membrane (Benz et al., 1976; Ketterer et al., 1971) . Assuming DPA binds the NMDAR at a site within the plasma membrane, we sought to identify whether the binding site is closer to the inner plasma membrane surface or to the external plasma membrane surface by examining the voltage dependence of DPA antagonism. Figure 6A3 ). The family of currents in Figure 6A3 was obtained by subtracting a family of currents in the presence of DPA alone from a family obtained in the combined presence of DPA and NMDA. Therefore, the capacitive effects of DPA shown in Figure 6A1 were eliminated from 6A3. It can be appreciated that the outward current relaxations from inhibition at negative potentials to a new steady-state current level at positive potentials was substantially slower than the capacitive charge movements ( Figure 6A1 ), which reflect the translocation of DPA through the membrane. This suggests that DPA translocation is not directly linked to relief from antagonism at positive potentials. Relaxations upon return to the negative holding potential were also sometimes resolvable in subtractions ( Figure 6A3 ).
The descriptions of relaxations in Figure 6A2 and 6A3 are summarized in Figure 6B . As previously documented, inherent voltage-dependent relaxations followed bi-exponential kinetics, A summary current-voltage curve for steady-state currents obtained from the voltage-pulse protocol is shown in Figure 6D and highlights the voltage-dependent nature of DPA-mediated This article has not been copyedited and formatted. The final version may differ from this version. Figure 6E ). This voltage dependence is weaker than that describing translocation of DPA through the membrane bilayer of hippocampal neurons (V 1/2 of +13 mV and a slope factor of ~39 mV) (Chisari et al., 2011) . These differences suggest that voltage dependence of NMDAR antagonism is unlikely to be associated directly with DPA's voltage-dependent translocation through the membrane bilayer.
To ensure that voltage dependence was observed across a range of DPA concentrations, we examined the effect of several DPA concentrations at -70 mV and at +40 mV within individual cells. We found that that the positive membrane potential weakened antagonism by DPA at all active concentrations tested (1, 3 and 10 µM)(data not shown; p < 0.01 by two-way ANOVA, N = 5). Although we found a main effect of both DPA concentration and voltage, there was no significant interaction, suggesting that depolarization decreased the effect of DPA similarly at each concentration.
Although the rectification of NMDA current in the absence of DPA in Figure 6 Figure 6D ). Arguing further that voltage-dependent current relaxations at +90 mV in nominally Mg 2+ -free solutions did not result from Mg 2+ contamination, we found that relaxations at +90 mV persisted in 0.1 mM disodium EDTA to chelate any residual Mg To pursue further the hypothesis that membrane association does not directly underlie DPA's antagonism of NMDAR function, we compared the rate of DPA's absorption to the plasma membrane, measured as membrane capacitance increase, with its rate of interaction with NMDARs. Figures 7A and 7B show both onset and offset of DPA antagonism during the response to 300 µM NMDA. The early components of both onset and offset were adequately described by a single exponential function. Although both onset and offset of block also often appeared to exhibit a slow component, it was difficult to distinguish this slow component from the ongoing slow desensitization of receptors, so we did not include this element in our analysis (see Figure 6A ). Average onset and offset values for 1 µM DPA in this protocol were 381.7 ± 85.3 ms and 790.5 ± 174.9 ms, respectively (N = 7; Figure 7E ).
To monitor membrane interactions, we used repetitive, brief 20 mV voltage pulses from the holding potential of -70 mV and measured changes in membrane capacitance. We found that DPA's interaction with the membrane exhibited an approximately 10-fold slower rate constant ( Figure 7C , D, E) than DPA's interaction with NMDARs. We have previously shown that DPAinduced capacitance changes of membrane and antagonism of GABA A R function can be rapidly reversed by BSA application to the cells (Chisari et al., 2011) . BSA is a well described scavenger of lipophilic agents (Bojesen and Hansen, 2003; Richieri et al., 1993) . In contrast, we found that BSA had no significant effect on the fast time constant of antagonism offset at NMDARs, with 5 s application of 1 µM DPA ( Figure 7F ). In sum, these data are consistent with the idea that DPA interacts directly with the NMDAR, at least at low concentrations, and that DPA's effects on the plasma membrane play only an indirect role in antagonism.
This article has not been copyedited and formatted. The final version may differ from this version. Channel blockers such as memantine exhibit slowed dissociation from NMDARs at negative membrane potentials, accounting for the voltage dependence of steady-state inhibition (Gilling et al., 2009; MacDonald et al., 1987) . We found that DPA (3 µM) exhibited qualitatively similar actions, where inhibition continued after ceasing application at -90 mV yet recovered at +50 mV ( Figure 8A ). Again, this behavior is opposite of that predicted if membrane partitioning plays an important role in modulation of NMDARs. The offset of NMDAR antagonism by memantine (10 µM) was faster at +50 mV than at -90 mV (the calculated time constants were 610.8 ± 127.6 ms at +50 mV and 2929.2 ± 1058.6 ms at -90 mV; N = 4 -7). Alternatively, the offset of DPA's NMDAR antagonism at +50 mV appeared qualitatively faster than at -90 mV (the calculated time constant was 2703.1 ± 545.1 ms at +50 mV; exponential fits could not be calculated at -90 mV with the same wash period; N = 5). This is in contrast to effects of DPA on GABA A Rs, where offset of DPA antagonism is dramatically slowed at positive membrane potentials (Chisari et al., 2011) . On the other hand, we observed that at these high concentrations of DPA (3 µM), BSA speeded recovery from antagonism ( Figure 8B ), consistent with the idea that membraneretained DPA has indirect access to the NMDAR.
We hypothesized that the counterintuitive voltage dependence of antagonism by an anion, and the behavior that contradicts actions at GABA A Rs, could be explained if outer membraneassociated DPA, but not inner-surface DPA, can access the NMDAR antagonism site. Because inner-membrane surface DPA (favored at positive membrane potentials) is resistant to washout (Chisari et al., 2011), we reasoned that antagonism might be restored following washout of DPA at +50 mV, by stepping the membrane potential back to -90 mV, as trapped inner-membrane surface DPA translocates back to the outer membrane surface ( Figure 9A, B) . In contrast to this prediction, we found that following DPA application at +50 mV ( Figure 9C ), NMDA currents were not significantly inhibited following return to -90 mV, measured 5 s following DPA washout This article has not been copyedited and formatted. The final version may differ from this version. and 5 s following repolarization. Alternatively, DPA applied at -90 mV on the same cells exhibited protracted antagonism following washout ( Figure 9D , E), as observed in the protocol in Figure 8 . This is in direct contrast to the pattern of membrane retention detected as membrane capacitance increases ( Figure 9F , G), which verified trapping of DPA in the membrane at +50 mV. DPA applied at +50 mV and washed away at +50 mV yielded larger capacitance increases than DPA washed on and off at a membrane potential of -90 mV throughout ( Figure 9H ). This pattern of results demonstrates that DPA trapped in the membrane at +50 mV and subsequently returned to the outer leaflet cannot significantly interact with NMDARs. Thus, the pool of DPA detectable electrically by capacitance measurements does not have direct access to the NMDAR. We conclude that voltage dependence of DPA does not arise by access to a site associated with the outer membrane leaflet.
Voltage-dependent channel blockers like ketamine and Mg 2+ exhibit sensitivity to the direction of current flow (MacDonald et al., 1987; MacDonald and Nowak, 1990) . Dissociation is accelerated and steady-state block is decreased by outward current at positive potentials (Chen and Lipton, 1997; Mennerick et al., 1998) . If DPA binds residues near the channel mouth, perhaps voltage dependence could be imparted to DPA actions through a similar interaction with permeant ions. To test whether DPA is also sensitive to the direction of current flow, we altered the reversal potential for NMDAR currents using a choline-rich whole-cell pipette solution. Under these conditions, reversal of currents occurs at approximately +50 mV instead of 0 mV, and Mg 2+ block but not DPA antagonism significantly increased (Figure 10 ). This result shows that voltage dependence is not derived from permeant ion interaction with DPA and verifies that DPA is unlikely to act through channel block.
This article has not been copyedited and formatted. The final version may differ from this version. In part, we examined DPA because of its similarity at GABA A Rs to sulfated neurosteroids, which also modulate NMDARs. DPA has superficially similar physicochemical properties to sulfated steroids (hydrophobicity, negative charge). Some sulfated neurosteroids positively regulate NMDARs; others negatively regulate (Weaver et al., 2000) . DPA exhibits potency at least 10-times greater than steroid inhibitors at NMDARs, and its effective concentration range is similar to widely used antagonists (low micromolar). Additionally, antagonism by some sulfated steroids is use dependent (Petrovic et al., 2005) , and the voltage dependence of DPA appears to be distinct from actions of neurosteroids (Park-Chung et al., 1997; Petrovic et al., 2005) .
These differences from neurosteroids may suggest a different site of interaction for DPA.
However, because the amino acid residues responsible for steroid antagonism remain unclear level of inhibition of peak current and steady-state current are comparable when scaled (bottom). C. Current response to NMDA (300 µM), then co-application of ketamine (2.5 µM), then a return to NMDA (left). In the same cell, ketamine (2.5 µM) was pre-applied for 10 s, followed by NMDA alone (300 µM, right). D. Current response to NMDA (300 µM), then coapplication of DPA (3 µM), followed by a return to NMDA for 30 s (top). After removal of excess DPA with BSA (0.1 mg/mL), NMDA (300 µM) was re-applied, followed by co-application of DPA (3 µM), then washout with saline and two 3 s pulses of NMDA (300 µM A. Current response to application of NMDA (300 µM), followed by co-application with DPA (1 µM), and then a return to NMDA alone. B. Exponential fits (red line) applied to onset and offset of DPA application. C. Capacitance response to 30 s application of DPA (1 µM), followed by a return to saline (40 s). D. Exponential fits (red line) applied to onset and offset of DPA application. E. Time constants derived from calculated exponential fits were summarized for both NMDA-induced current inhibition (I NMDA inhibition, N = 7) and increase in plasma membrane capacitance (C m increase, N = 4). F. Current response to application of NMDA (300 µM),
followed by co-application with DPA (1 µM), and then co-application with BSA (0.1 mg/mL).
Exponential fits were applied to offset of DPA in the presence or absence of BSA (bottom left)
This article has not been copyedited and formatted. The final version may differ from this version. and found to be statistically non-significant (bottom right). For E *** P < 0.001 by unpaired t-test compared with I NMDA inhibition. Figure 8 . DPA antagonism offset is slowed at negative membrane potentials. A. Current responses at -90 mV (inward current) and +50 mV (outward current) to application of NMDA (300 µM), followed by co-application with either memantine (10 µM, top) or DPA (3 µM, bottom), and then a return to NMDA alone. In both cases, antagonism offset at the positive potential is faster than at the negative potential. The offset of DPA at -90 mV is shown enlarged (inset). B.
Current responses at -90 mV to application of NMDA (300 µM) in the absence (top) and presence (bottom) of DPA (3 µM), followed by a return to NMDA alone, and then co-application with BSA (0.1 mg/mL). membrane retention, we performed a similar DPA application protocol at two membrane potentials but measured membrane capacitance. We delivered a +5 mV pulse at a holding potential of -90 mV before (black line) and after application of DPA (3 µM, red line) to monitor capacitive current. DPA was applied for 10 s (followed by 5 s washout) at +50 mV (F) or at -90
This article has not been copyedited and formatted. The final version may differ from this version. mV (G). There was stronger retention of DPA-induced membrane capacitance when DPA was applied at +50 mV (H, N = 4). Thus, while DPA is retained in the membrane longer at +50 mV, it is retained on receptors longer at -90 mV. For E and H: * P < 0.05; ** P < 0.01 by paired t-test compared with application at +50 mV. This article has not been copyedited and formatted. The final version may differ from this version. 
